To Örebro University

oru.seÖrebro University Publications
Planned maintenance
A system upgrade is planned for 10/12-2024, at 12:00-13:00. During this time DiVA will be unavailable.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study
Örebro University, School of Medical Sciences. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden .
Örebro University, School of Medical Sciences.ORCID iD: 0000-0002-4811-2330
Show others and affiliations
2022 (English)In: World Psychiatry, ISSN 1723-8617, E-ISSN 2051-5545, Vol. 21, no 3, p. 452-459Article in journal (Refereed) Published
Abstract [en]

Accumulating evidence suggests a higher risk for cardiovascular diseases among individuals with mental disorders, but very little is known about the risk for overall and specific groups of cardiovascular diseases in people with attention-deficit/hyperactivity disorder (ADHD). To fill this knowledge gap, we investigated the prospective associations between ADHD and a wide range of cardiovascular diseases in adults. In a nationwide population-based cohort study, we identified 5,389,519 adults born between 1941 and 1983, without pre-existing cardiovascular diseases, from Swedish registers. The study period was from January 1, 2001 to December 31, 2013. Incident cardiovascular disease events were identified according to ICD codes. Hazard ratios (HR) with 95% confidence intervals (CI) were calculated using Cox proportional hazards regression model, with ADHD as a time-varying exposure. After an average 11.80 years of follow-up, 38.05% of individuals with ADHD versus 23.57% of those without ADHD had at least one diagnosis of cardiovascular disease (p<0.0001). ADHD was significantly associated with increased risk of any cardiovascular disease (HR=2.05, 95% CI: 1.98-2.13) after adjusting for sex and year of birth. Further adjustments for education level, birth country, type 2 diabetes mellitus, obesity, dyslipidemia, sleep problems and heavy smoking attenuated the association, which however remained significant (HR=1.84, 95% CI: 1.77-1.91). Further adjustment for psychiatric comorbidities attenuated but could not fully explain the association (HR=1.65, 95% CI: 1.59-1.71). The strongest associations were found for cardiac arrest (HR=2.28, 95% CI: 1.81-2.87), hemorrhagic stroke (HR=2.16, 95% CI: 1.68-2.77), and peripheral vascular disease/arteriosclerosis (HR=2.05, 95% CI: 1.76-2.38). Stronger associations were observed in males and younger adults, while comparable associations were found among individuals with or without psychotropic medications and family history of cardiovascular diseases. These data suggest that ADHD is an independent risk factor for a wide range of cardiovascular diseases. They highlight the importance of carefully monitoring cardiovascular health and developing age-appropriate and individualized strategies to reduce the cardiovascular risk in individuals with ADHD.

Place, publisher, year, edition, pages
Masson SpA , 2022. Vol. 21, no 3, p. 452-459
Keywords [en]
Attention-deficit/hyperactivity disorder, arteriosclerosis, cardiac arrest, cardiovascular diseases, hemorrhagic stroke, peripheral vascular disease, psychiatric comorbidities, psychotropic medications
National Category
Public Health, Global Health, Social Medicine and Epidemiology Psychiatry
Identifiers
URN: urn:nbn:se:oru:diva-101158DOI: 10.1002/wps.21020ISI: 000850880700021PubMedID: 36073682Scopus ID: 2-s2.0-85137588892OAI: oai:DiVA.org:oru-101158DiVA, id: diva2:1694330
Funder
Swedish Research Council, 201802599The Swedish Brain Foundation, FO2021-0115Forte, Swedish Research Council for Health, Working Life and Welfare, 2019-00176European Commission, 754285 667302 965381Swedish Society for Medical Research (SSMF)Available from: 2022-09-09 Created: 2022-09-09 Last updated: 2022-09-21Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Authority records

Li, LinGarcia-Argibay, MiguelDobrosavljevic, MajaLarsson, Henrik

Search in DiVA

By author/editor
Li, LinGarcia-Argibay, MiguelDobrosavljevic, MajaLarsson, Henrik
By organisation
School of Medical Sciences
In the same journal
World Psychiatry
Public Health, Global Health, Social Medicine and EpidemiologyPsychiatry

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 389 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf